Study Title
Evaluating the Effects of Segmental/Super Selective Treatment Utilizing Flex-dosing in Treating Unresectable HCC With Y90 SIR-Spheres
Study Details
Description:
The overall objective of this research study is to evaluate outcomes associated with flex-dosing in Y90 SIR-Sphere administration in a prospective cohort of unresectable HCC patients eligible for segmental/super selective treatment at Methodist Dallas Medical Center (MDMC).
Sponsor:
Methodist Health System
Contacts:
Crystee Cooper, DHEdclinicalresearch@mhd.com
214-947-1280
Zaid Haddadin, MSclinicalresearch@mhd.com
214-947-4604
Government Study Link:
NCT04903548 - Click here to see study onClinicalTrials.gov